Placebo group: What happens after a COVID vaccine is authorized?

If a coronavirus vaccine is authorized in the United States before the end of the year, will trial participants who received a placebo rush out to get vaccinated?

Rust Belt upstart Lordstown Motors set to make Nasdaq debut

Could a new Tesla-like upstart be the savior of a once-mighty Ohio steel region ravaged by deindustrialization?

Sweden sticks to its guns as COVID cases rise

Sweden is seeing an uptick in coronavirus infections and introducing targeted measures, but the country that famously refused to lock down is sticking to its guns and insisting coercive methods are not the way to go.

Huawei sales up, but growth slows under virus, US pressure

Chinese tech giant Huawei, one of the biggest makers of smartphones and switching equipment, said Friday its revenue rose 9.9% in the first nine months of this year, but growth decelerated in the face of U.S. sanctions and the coronavirus pandemic.

Tesla 'full self-driving' vehicles can't drive themselves

Earlier this week, Tesla sent out its "full self-driving" software to a small group of owners who will test it on public roads. But buried on its website is a disclaimer that the $8,000 system doesn't make the vehicles autonomous and drivers still have to supervise it.

FDA approves first COVID-19 drug: antiviral remdesivir

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.